Semaglutide: The Popular GLP-1 Receptor Agonist with Many Potential Medical Uses

Semaglutide is emerging as a wonder drug for management of various metabolic diseases. Originally approved for type 2 diabetes, this glucagon like peptide-1 (GLP-1) receptor agonist is now showing promise for treating obesity, non-alcoholic steatohepatitis (NASH), and neurodegenerative diseases like Alzheimer’s and Parkinson’s. Let’s explore the therapeutic potential of semaglutide and how it acts as …

Read more

Type 2 Diabetes & Brain Effects in Native Americans: What A New Study Suggests

A new study looked at how having diabetes may impact brain health in Native Americans. The researchers found that the longer someone had diabetes, the more it affected their brain. But other health issues like obesity did not appear to impact the brain as much. Key facts: The study involved 51 Native Americans with type …

Read more